The Nevada Senate has approved a joint resolution that calls on Congress to reschedule certain psychedelics, provide protections for people using the substances in compliance with state law and streamline research.
About a week after the legislation from Sen. Rochelle Nguyen (D) cleared committee, the full chamber passed it in an 18-2 vote on Friday. It now moves to the Assembly for consideration.
Nguyen said on the floor that the proposal “sets forth the argument that certain research and therapeutic trials have demonstrated promising results for the use of these substances in the treatment of disorders such as traumatic brain injury, post-traumatic stress disorder, certain depressive disorders and other mental health conditions.”
“The measure notes the low abuse potential for classic psychedelics and highlights their safety in therapeutic session settings,” she said, adding that “SJR 10 expresses Nevada’s continued support for expanded research opportunities…and urges Congress and the appropriate federal agencies to increase related funding” for psychedelic medicines.